Literature DB >> 25952322

The diagnosis and management of interstitial lung diseases.

Adam Wallis1, Katherine Spinks2.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25952322     DOI： 10.1136/bmj.h2072

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  13 in total

Review 1.  Tyrosine Kinase Inhibitor-Induced Interstitial Lung Disease: Clinical Features, Diagnostic Challenges, and Therapeutic Dilemmas.

Authors:  Rashmi R Shah
Journal:  Drug Saf       Date:  2016-11       Impact factor: 5.606

2.  Serum 25-Hydroxyvitamin D Concentrations Are Associated with Computed Tomography Markers of Subclinical Interstitial Lung Disease among Community-Dwelling Adults in the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Samuel M Kim; Di Zhao; Anna J Podolanczuk; Pamela L Lutsey; Eliseo Guallar; Steven M Kawut; R Graham Barr; Ian H de Boer; Bryan R Kestenbaum; David J Lederer; Erin D Michos
Journal:  J Nutr       Date:  2018-07-01       Impact factor: 4.798

Review 3.  Fibrosis Related Inflammatory Mediators: Role of the IL-10 Cytokine Family.

Authors:  Erna Sziksz; Domonkos Pap; Rita Lippai; Nóra Judit Béres; Andrea Fekete; Attila J Szabó; Ádám Vannay
Journal:  Mediators Inflamm       Date:  2015-06-24       Impact factor: 4.711

4.  Significant decrease in peripheral regulatory B cells is an immunopathogenic feature of dermatomyositis.

Authors:  Wenli Li; Xiaolan Tian; Xin Lu; Qinglin Peng; Xiaoming Shu; Hanbo Yang; Yuanli Li; Yan Wang; Xuezhi Zhang; Qingyan Liu; Guochun Wang
Journal:  Sci Rep       Date:  2016-06-07       Impact factor: 4.379

Review 5.  Human Lung Mononuclear Phagocytes in Health and Disease.

Authors:  Faezzah Baharom; Gregory Rankin; Anders Blomberg; Anna Smed-Sörensen
Journal:  Front Immunol       Date:  2017-05-01       Impact factor: 7.561

Review 6.  Efficacy and safety of mycophenolate mofetil in the treatment of rheumatic disease-related interstitial lung disease: a narrative review.

Authors:  Giulia Cassone; Marco Sebastiani; Caterina Vacchi; Gian Luca Erre; Carlo Salvarani; Andreina Manfredi
Journal:  Drugs Context       Date:  2021-01-15

7.  Interstitial Lung Disease in Common Variable Immunodeficiency.

Authors:  Joao Pedro Lopes; Hsi-En Ho; Charlotte Cunningham-Rundles
Journal:  Front Immunol       Date:  2021-03-11       Impact factor: 7.561

8.  Risk assessment in interstitial lung disease: the incremental prognostic value of cardiopulmonary ultrasound.

Authors:  Wei-Wei Zhu; Hong Li; Yi-Dan Li; Lanlan Sun; Lingyun Kong; Xiaoguang Ye; Qizhe Cai; Xiu-Zhang Lv
Journal:  BMC Pulm Med       Date:  2021-07-15       Impact factor: 3.317

9.  Deletion of SMARCA4 impairs alveolar epithelial type II cells proliferation and aggravates pulmonary fibrosis in mice.

Authors:  Danyi Peng; Daozhu Si; Rong Zhang; Jiang Liu; Hao Gou; Yunqiu Xia; Daiyin Tian; Jihong Dai; Ke Yang; Enmei Liu; Yujun Shi; Q Richard Lu; Lin Zou; Zhou Fu
Journal:  Genes Dis       Date:  2017-10-25

10.  Acute Exacerbation of Interstitial Lung Disease as a Sequela of COVID-19 Pneumonia.

Authors:  Mario Fonseca; Ross Summer; Jesse Roman
Journal:  Am J Med Sci       Date:  2020-08-11       Impact factor: 2.378
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.